Comparative molecular field analysis (CoMFA) was performed on a series of 47 compounds as potent selective human β 3 -adrenoceptor (AR) agonists. Low energy conformation of the most active compound in the chosen series was found by Molecular dynamics simulated annealing method. The statistically significant model was established from 33 molecules, which were validated by evaluation of test set of 14 compounds. The fit atom based alignment yielded best predictive CoMFA model (r 2 cv =0.583, r 2 cnv =0.992, F Value=534.974, SEE=0.074, r 2 pred =0.743 with six components). The contour maps obtained from 3D-QSAR studies were appraised for the activity trends of the molecules analyzed. The results indicate that the steric, electrostatic substituents play significant role in β 3 -AR activity and potency of these compounds. The data generated from the present study can be used as putative pharmacophore in the design of novel, potent, human β 3 -adrenoceptor agonists as anti-obesity and anti-diabetic agents.
Introduction
The β 3 -adrenergic receptor (β 3 -AR) 1 is a G-protein-coupled seven trans membrane domain receptor that is expressed mainly in adipose tissue where the excess fats are stored. 2 The β 3 -AR plays a major role in mediating lipolysis in white adipocyte tissue (WAT) and thermogenesis (energy expenditure) in brown adipocyte tissue (BAT). 3 It was found that stimulation of β 3 -AR by selective agonists produced remarkable anti-obesity effects. 3 ,4 β 3 -AR agonists have also been found to cause insulin sensitisation. 5, 6 A set of lead compounds identified for β 3 -AR agonistic activity are given in scheme 1. [5] [6] [7] [8] [9] All the developed new chemical entities for β 3 -AR produced significant effect in rodents but failed to produce similar effects in humans. This has been 
Scheme 1
Three-dimensional structure of β 3 -AR has not been resolved yet and the cause of their broad substrate specificities of β 3 -AR agonists is not known. Therefore, we decided to use a ligandbased approach to extrapolate quantitative structure-activity relationships (QSARs) 12 for known β 3 -AR agonists. CoMFA 13 method, which calculates steric and electrostatic properties according to Lennard-Jones and Coulomb potentials respectively, from the 3D structures of a series of compounds, has been employed in this study. CoMFA model can characterize the relative changes in magnitude of steric and electrostatic fields as a function of the sample chosen from the data set. It can account for the variance in measured biological activity, giving rise to the capacity to predict anti-obesity and anti-diabetic activities of new β 3 -AR agonist analogous. As a result only agonists with high activities can be selected for syntheses through the analysis. When no structural information is available, methods that investigate conformational space (e.g., using simulated annealing 16 and cluster analysis) may find the best match between various ligands. The fragment libraries in SYBYL database were used as building blocks for the construction of most active molecule 21 in the training set. A preliminary minimization was performed to remove close atom contacts by 1000 cycles of minimization using standard Tripos force field 17 (with 0.005 kcal/mol energy gradient convergence criterion). The structure was next subjected to molecular dynamic simulation to heat the molecule at 700k for 1000 fs followed by anneal the molecule to 200k for 1000 fs. All the remaining molecules were constructed using 21 as template and subjected to simple minimization and filled with Gasteiger-Huckel charges. 18 The minimized molecules were superimposed by the atom-fit method choosing the atoms 1-6 as shown Scheme 2. The superimposed structures are shown in Figure 1 . 
CoMFA study
Conventional CoMFA was performed with the QSAR option on SYBYL software. The training set of 33 aligned molecules was put into a 3D grid with a spacing of 2.0 Å. The steric and electrostatic fields were then calculated using an sp 3 C-atom with +1 charge and the default cutoff energy was set to 30 kcal/mol. The CoMFA QSAR equations were developed with the Partial Least Square (PLS) algorithm. 19 The cross validation of the model was performed using Leave One Out (LOO). The final non-cross-validated model was developed using optimal number of components that had both the highest r 2 ncv value and the smallest value of standard error predictions. To improve the signal-to-noise ratio, all leave-one-out calculations were performed with column filter value which was set to 2. The predictive r 2 was used to evaluate the predictive power of the CoMFA model, and was based only on molecules from the test set. Several CoMFA models were built by considering permutations of molecules between training and test sets. The best model amongst them was chosen on the basis of high r 
Results and Discussion
The two models derived by fit-atom based alignment using steric and electrostatic fields produced r 2 cv 0.670 and 0.583, respectively. Later various CoMFA models were generated using different combination of training set and test set, however none of these models lead to significant improvement in the r 2 cv and r 2 values of the models.
Statistical analysis
The CoMFA model-I developed using 30 compounds in the training set, which exhibited to highest r The experimental, calculated activities and residual values for training set as well as test set are given in Table 2 . A plot of experimental versus calculated β 3 -AR agonists activities is illustrated in Figure 2 . The best 3D-QSAR equation derived from the above analysis is, N=Number of compounds; r 
Contour map analysis
In the present study out of the two CoMFA models developed initially only the CoMFA model-II was taken up for contour map analysis. The derived CoMFA model-I relatively poor external test set prediction value of 0.462. The results of a CoMFA are best interpreted as CoMFA electrostatic and steric field graphs. These graphs show regions in the space around the molecules as solid contoured volumes, where specific steric or electronic interactions favorable or unfavourable for biological activity. In general, "Bio-Activity Measurement" is correlated with: more bulk near green; less bulk near yellow; more positive charge near blue and more negative charge near red. The CoMFA coefficient contour maps of steric and electrostatic potentials are displayed in Figures 3 and 4 , respectively, along with the most active compound 21 as the reference. The steric contour map shows a green region at substituents on aryl ring in aryloxypropanolamine, indicating more bulky substituent is preferred at meta position on the aryl ring to result in higher bioactivity. This is also consistent with the fact that molecules 21, and 32 with -NHSO 2 CH 3 substituents at meta position show high activity (EC 50 1 nM) than the others. On the other hand derivatives bearing less bulky or no substituents on aryl ring at meta position show low bioactivity, which is consistent with the fact that molecule 12 has very poor activity (EC 50 1020 nM). This indicates that bulky substituents at meta position on aryl ring on arylethanolamine or aryloxy propanolamine give higher affinity towards β 3 -AR agonists activity. In addition, the blue regions near aryl nucleus of the aryloxypropanolamine portion in the electrostatic contour map suggest that substituting a group or atom with a less electronegative group at meta position on an aryl ring system would yield a higher activity. It was found that molecules 21 and 32, which have less electronegative group like -NHSO 2 CH 3 , show higher activities than the others. On the other hand high electronegative group or atom on an aryl ring system would yield a very poor activity as in 12, which has chlorine atom.
A small red region inside the blue contour on the para position of the aryl ring of the aryloxypropanolamine section suggests that an electronegative group or atom is essential for biological activity. All the molecules have hydroxyl group on the para position of the aryl ring indicating that the hydroxyl group is essential for the biological activity. This hydroxyl group is important for making a hydrogen bond with an amino acid residue present in transmembrane 5 domain (TM5) of β 3 -AR reported by Strosberg. 20 The compound 23, 24, 25, 26 and 28 are poor β 3 -AR agonists (EC 50 in the range 187-665 nM) due to electronegative atom nitrogen and also bulky indole ring substituted on aryl ring. In addition this molecule does not possess the essential hydroxyl group on the para position of the aryl ring. The compound 1, 2 and 33 are fairly potent β 3 -agonists (EC 50 in the range 5-6 nM) because of bulky and less electronegative substituents on aryl ring. Compounds 5, 9 and 13 are better active towards β 3 -AR (EC 50 in the range 43-90 nM) due to hydroxyl group substituted on aryl ring. Compounds 9, 10, 14, 15, 16, 17 and 18 (EC 50 in the range 30-250 nM) enter into the yellow contours, which indicate that a sterically less long chain is necessary for the biological activity. The three-dimensional contour map does not show any other steric and electronic fields major correlation with β 3 -AR agonists activity.
Conclusions
The 3D QSAR study carried out using CoMFA has led to the identification of the regions of importance for steric and electronic interactions. The derived models well explain the observed variance in the activity and also provide important insight into structural variations that can lead to the design of novel and highly potent β 3 -AR agonists. The contour map analysis indicates that the bulky and less electronegative substituents on aryl ring are favorable, unsubstitued and electronegative atoms such as chlorine, fluorine etc. in the aryl ring of the arylethanolamine are unfavorable for β 3 -AR agonistic activity.
